Mastellos, Dimitrios C., Blom, Anna M., Connolly, E. Sander, Daha, Mohamed R., Geisbrecht, Brian V., Ghebrehiwet, Berhane, Gros, Piet, Hajishengallis, George, Holers, V. Michael, Huber-Lang, Markus, Kinoshita, Taroh, Mollnes, Tom E., Montgomery, Robert A., Morgan, B. Paul ORCID: https://orcid.org/0000-0003-4075-7676, Nilsson, Bo, Pio, Ruben, Ricklin, Daniel, Risitano, Antonio M., Taylor, Ronald P., Mantovani, Alberto, Ioannidis, John P. A. and Lambris, John D.
2019.
'Stealth' corporate innovation: an emerging threat for therapeutic drug development.
Nature Immunology
20
(11)
, pp. 1409-1413.
10.1038/s41590-019-0503-1
|
Preview |
PDF
- Accepted Post-Print Version
Download (314kB) | Preview |
Official URL: http://dx.doi.org/10.1038/s41590-019-0503-1
| Item Type: | Article |
|---|---|
| Date Type: | Publication |
| Status: | Published |
| Schools: | Schools > Medicine |
| Publisher: | Nature Publishing Group |
| ISSN: | 1529-2908 |
| Date of First Compliant Deposit: | 16 December 2019 |
| Date of Acceptance: | 20 August 2019 |
| Last Modified: | 30 Nov 2024 16:30 |
| URI: | https://orca.cardiff.ac.uk/id/eprint/127575 |
Citation Data
Cited 4 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
![]() |
Edit Item |





Dimensions
Dimensions